Form 4: Stepan Co. Executive Sharon Purnell Reports Stock Transactions
SEC Form 4 Filing
Sharon Purnell, VP & CHRO of Stepan Co., reports acquisition and disposal of common stock and derivative securities.
Summary
- On March 4, 2025, Sharon Purnell, VP & CHRO of Stepan Co., reported transactions involving Stepan Co. common stock.
- Purnell acquired 285 shares of common stock at $57.275 per share through the settlement of restricted stock units (RSUs).
- She also disposed of 93 shares at $57.275 per share to cover tax liabilities related to the vesting of RSUs.
- Following these transactions, Purnell directly owns 203.863 shares and indirectly owns 68.348 shares through an ESOP II Trust.
- On March 3, 2025, Purnell acquired 3,132 Restricted Stock Units, 1,566 Performance Shares, and 4,422 Stock Appreciation Rights.
Sentiment
Score: 6
Explanation: Neutral sentiment. The transactions are routine and reflect standard executive compensation practices. The acquisition of shares and derivative securities is a mildly positive signal, while the disposal of shares for tax liabilities is a neutral event.
Positives
- Acquisition of shares and derivative securities indicates confidence in the company's future performance.
Negatives
- Disposal of shares to cover tax liabilities could be seen as a minor negative, but is a common practice.
Risks
- The vesting of performance shares is contingent on Stepan Company achieving certain performance goals, which may not be met.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of the equity awards suggest a multi-year horizon for executive compensation and company performance.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are routinely disclosed to the SEC. These transactions can provide insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Equity compensation practices, such as granting RSUs, performance shares, and stock appreciation rights, are standard across publicly traded companies, including Stepan Co.'s competitors in the specialty chemical industry.
- The vesting schedules and performance metrics associated with these awards are typically designed to align executive incentives with long-term shareholder value creation, similar to practices observed at companies like Dow, BASF, and DuPont.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they involve a relatively small number of shares.
- Employees holding RSUs or performance shares are indirectly affected by the vesting of these awards.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of grant for Restricted Stock Units, Performance Shares, and Stock Appreciation Rights |
| 03/03/2026 | First vesting date for Restricted Stock Units and Stock Appreciation Rights |
| 03/03/2028 | Final vesting date for Restricted Stock Units |
| 12/31/2027 | End of performance period for Performance Shares |
| 03/04/2025 | Date of common stock transactions (acquisition and disposal) |
| 03/04/2027 | Final vesting date for Restricted Stock Awards |
| 03/05/2025 | Date of Form 4 filing |
| 03/03/2035 | Expiration date for Stock Appreciation Rights |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.